论文部分内容阅读
目的探讨重型脑室出血急性脑积水的治疗,以降低延期脑积水的发病率。方法在脑室持续引流及尿激酶灌注的基础上,向腰蛛网膜下腔注入尿激酶。结果经尿激酶治疗后,4例未发生延期脑积水,占80%;1例为高压型脑积水,行“脑室腹腔分流术”,占20%。结论在脑室持续引流及尿激酶灌注的基础上,向腰蛛网膜下腔注入尿激酶,能降低延期脑积水的发生率。
Objective To investigate the treatment of acute hydrocephalus in severe intraventricular hemorrhage to reduce the incidence of delayed hydrocephalus. Methods Based on continuous ventricular drainage and urokinase perfusion, urokinase was injected into the lumbar subarachnoid space. Results After urokinase treatment, 4 cases did not have delayed hydrocephalus, accounting for 80%; 1 case of high-pressure hydrocephalus, the “ventricle peritoneal shunt”, accounting for 20%. Conclusions Continuous intraventricular drainage and urokinase perfusion based on the injection of urokinase into the lumbar subarachnoid space can reduce the incidence of delayed hydrocephalus.